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Abstract
 This review documents all the new homoisoflavonoids (HIFs) that have been reported since 2007, whose total number has 
grown from 159 in 2007 to 295 at the present time. This review contains their structures, biological sources, plant parts they 
are obtained from, and, if reported, their optical rotations and melting points. The same classification is followed as an earlier 
review to ease reference to both reviews. This review takes note of the recent revision of plant families that were known 
to contain HIFs that have now been merged into one big family, Asparagaceae. Homoisoflavonoids also occur in Fabaceae 
and others. Two taxa, Ophiopogoan japonicus (Asparagaceae) and Caesalpinia sappan (Fabaceae), have been the source of many 
HIFs. These are briefly summarized. The biological properties of HIFs are also reviewed under the topics such as antioxidant, 
anti-inflammatory, antimicrobial, antidiabetic, and cytotoxic. The review also surveys the total synthesis of natural HIFs. All 
new compounds are classified and tabulated following the same style as the previous review.
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Homoisoflavonoids represent a subclass of the larger family 
of flavonoids (1) that are uniquely characterized by having 
one more carbon (C-9) than the regular flavonoids in their 
16-carbon skeleton (2) (Figure 1). Labeling studies1,2 have 
provided evidence to support the biogenetic hypothesis that 
they are biosynthesized from a 15-carbon flavonoid 
precursor.
This review is a follow-up of an earlier one in 20073 list-
ing the 159 compounds which were known then. The total 
number of naturally occurring HIFs has now reached 295 
and this review documents the new metabolites belonging to 
this class that have been discovered since then. This review 
is based on a survey of publications that have appeared in 
Scopus and the Science Citation Index during the period 
2007 to 2018.
Five important review publications relevant to the field of 
HIFs have appeared during this review period. The first is a 
review of the chemical structures, plant origins, ethnobotany, 
and biological activities of homoisoflavanones,4 listing 129 
compounds. This number is less than the 159 recorded in the 
earlier review, because the authors focused only on metabo-
lites having a selected number of structural types under this 
class. The second is a review of HIFs and their 
pharmacological activities.5 This lists 240 naturally occur-
ring HIFs and contains a comprehensive listing of all natural 
HIFs known at the time of the review (2014). The coverage 
is limited to recording all the metabolites and discusses phar-
macological properties. The third review is devoted to one 
homoisoflavonoid, namely, brazilin.6 Brazilin (3) (Figure 2) 
is the major and most biologically active of the 3 HIFs found 
in the heartwood of Caesalpinia sappan. The review docu-
ments the scientific evidence supporting the folkloric uses of 
brazilin as an antioxidant and antibacterial, with anti-inflam-
matory, antiphotoaging, hypoglycemic, vasorelaxant, hepa-
toprotective, and antiacne activity (more on this compound, 
later). The fourth is a phytochemical, ethnomedicinal, and 
pharmacological review of the taxon Ophiopogon japonicus, 
1  Stellenbosch Institute for Advanced Study,  Wallenberg Research Centre 
at Stellenbosch University, South Africa 
2  Department of Chemistry, Center of Synthesis and Catalysis, University 
of Johannesburg, South Africa 
Corresponding Author: 
Berhanu M. Abegaz, Stellenbosch Institute for Advanced Study, 
Wallenberg Research Centre at Stellenbosch University, Stellenbosch 
7600, South Africa.




© The Author(s) 2019
Article reuse guidelines:
 sagepub. com/ journals- permissions
DOI: 10.1177/1934578X19845813
 journals. sagepub. com/ home/ npx
 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 
License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without 
further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-
access-at-sage).
Natural Product Communications2
a functional food and commercial medicinal plant, whose 
biological activities are due to 3 major classes of metabo-
lites: saponins, HIFs, and polysaccharides.7 The published 
evidence summarized in this review points to the HIFs con-
tributing to the anti-inflammatory and antioxidant properties 
of the medicinal plant. The fifth review is the first compre-
hensive report in recent times devoted to what is often 
referred to as Dragon’s blood. This review sheds much 
needed light to clarify the confusion that prevailed on the 
source and composition of Dragon’s blood which refers to 
red saps and resins derived from a few disparate taxa.8 
Although this multipurpose material was originally from 
Dracaena species, the review reveals that there are 4 distinct 
plant genera, namely Croton (Euphorbiaceae), Dracaena 
(Dracaenaceae, now: Asparagaceae), Daemonorops 
(Palmaceae), and Pterocarpus (Fabaceae) that are described 
in the literature as sources of Dragon’s blood. Of the 4 gen-
era, only Dracaena cinnabari8 and Dracaena cochinchinen-
sis9-11 contain HIFs.
Distribution of HIFs
Many of the plant families that were known to produce HIFs, 
such as Anthericaceae, Liliaceae, Convallariaceae, 
Dracaenaceae, and Hyacinthaceae, have now been grouped 
under one big family, Asparagaceae (Accessed September 
13, 2018 [http://www. plan tsof thew orld online. org/ taxon/ urn: 
lsid: ipni. org: names: 481889-1]). So, all references to these 
families are recorded as Asparagaceae in this review. There 
are now 7 other families besides Asparagaceae that are 
known to produce HIFs: Amarillidaceae, Araliaceae, 
Fabaceae, Orchidaceae, Polygonaceae, Portolucaceae, 
Rosaceae, Meliaceae, Polypodiaceae, and Similacaceae. By 
far the majority of HIFs is derived from the family 
Asparagaceae, a much lesser number from Fabaceae, and 1 
or 2 genera belonging to the other families. Many names of 
species have also changed. For example, C. sappan L. is 
considered as the synonym of Biancaea sappan (L.) Tod. and 
taxonomic information for this taxon from Kew’s http://
www. plan tsof thew orld online. org/ (Accessed September 13, 
2018 [http://www. plan tsof thew orld online. org/ taxon/ urn: 
lsid: ipni. org: names: 481889-1]) is given using the latter. To 
avoid confusion, we have retained the earlier names at the 
taxon level.
Advances in Extraction and Separation Methods
One of the major challenges in the study of secondary metab-
olites has always been their purification and isolation from 
complex plant extracts.
The usual methods involve silica gel chromatography, 
which inevitably results in the irreversible adsorption of 
some of the components and in some cases even a change in 
the integrity of the metabolites. In this regard, there have 
been some advances reported during the period under review 
of gentler methods of isolation of HIFs. Xu et al have 
reported the successful separation of 4 HIFs from C. sappan 
by high-speed counter-current chromatography (HSCCC).12 
The crude extract of C. sappan was fractionated by HSCCC 
using a 2-phase solvent system consisting of chloro-
form-methanol-water (4:3:2, v/v/v). The separation condi-
tions were: flow rate, 1.0 mL/min; revolution speed, 900 
rpm; detection wavelength, 280 nm; separation temperature, 
25°C; sample size, 120 mg crude sample dissolved in a mix-
ture of the upper and lower phases (10 mL each). The reten-
tion of the stationary phase was 83%. This method delivered 
5 mg of 3′-deoxysappanol (4), 8 mg of 3-deoxysappanone 
(5) B, 20 mg of 4-O-methylsappanol (8), and 18 mg of bra-
zilin (3) in one step from 120 mg of an ethyl acetate extracted 
fraction of C. sappan (Figure 2).
In another instance Ma et al13 reported a method that com-
bines supercritical fluid extraction and HSCCC to extract 
and purify HIFs from O. japonicus. Thus, in a single opera-
tion, 140 mg crude extracts were separated and yielded 15.3 
mg of methylophiopogonanone A (9) (96.9% purity), 4.1 mg 
of 6-formyl-isoophiopogonone A (10) (98.3% purity), and 
13.5 mg of 6-formyl-isoophiopogonanone A (11) (97.3% 
purity) (Figure 2).
Uddin et al have reported a centrifugal partition chroma-
tography (CPC)-based one-step isolation of sappanol (7) and 
brazilin (3) from C. sappan.14 Using the solvent system, 
ethyl acetate:acetonitrile:water, 1:1:2, v/v, the ethyl 
Figure 1. General scaffolds of a flavonoid and an HIF.
Figure 2. Examples of HIFs.
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acetate-soluble material (350 mg) was subjected to CPC to 
yield the 2 HIFs.
Theoretical Studies on HIFs
As this class of compounds are more explored in terms of 
their structural diversity and biological properties, it becomes 
important to obtain a deeper insight into their properties 
through theoretical studies. We have observed such studies 
during the last decade that address the electronic distribution 
of HIFs. Discrete Fourier Transform (DFT) calculations of 
nuclear magnetic shielding for optimized geometries of HIFs 
show good correlations with experimentally measured 
values.15
More effective chiroptical methods are now available16,17 
to solve absolute configuration issues. These involve combi-
nations of electronic and vibrational chiroptical spectro-
scopic methods and interpretations of measured spectra with 
the aid of density functional theory calculations.
These methods18 were employed in determining the abso-
lute configuration of 5,7-dihydroxy-6-methoxy-3-(9-hy-
droxy-phenylmethyl)-chroman-4-one (12). This substance 
had been isolated from the dry leaves of Polygonum ferru-
gineum,19 now renamed as Persicaria ferruginea (Wedd.) 
Soják (Polygonaceae), and from Polygonum senegalense20 
(Persicaria senegalense (Meisn.) Soják), with widely differ-
ing optical rotation values. The former group reported [α]D 
−8.67 in dichloromethane, while the latter group reported a 
value of +41 in methanol. Interestingly, a third group21 had 
isolated the same substance from Polygonum libatum with 
[α]D of zero and presumed the isolate to be a racemic mix-
ture. Batista et al18 investigated and first made the unex-
pected discovery that the differences were a result of the 
solvents used for the measurements and not due to different 
ratios of enantiomers. The specific rotation of 12 in chloro-
form was +44, which is much closer to the value obtained in 
methanol than to that measured in dichloromethane. These 
authors used this observation to caution on the risks of com-
paring optical rotation values in different conditions, even 
when apparently similar solvents are used. The absolute con-
figuration of 12 was unambiguously assigned as 3R,9R by 
means of a combination of chiroptical methods and theoreti-
cal calculations.
Ophiopogon japonicus and C. sappan
Ophiopogon japonicus (Thunb.) Ker Gawl. and C. sappan 
(now called Biancaea sappan (L.) Tod. have been the subject 
of intense investigations during the last 10 years. Ophiopogon 
japonicus is an important medicinal plant which is native to 
Central and South China to Vietnam, temperate East Asia to 
the Philippines and has been introduced to some areas of cen-
tral South America (Argentina, Uruguay, and Paraguay). 
Besides its use in the treatment of a variety of ailments, it is 
considered as a functional food in China and other East Asian 
countries. The main active ingredients are believed to be ste-
roidal compounds and HIFs.7 The Chen review7 of this plant 
records 36 HIFs reported from O. japonicus. Further metab-
olites have been reported since then. Thus, 18 new HIF 
metabolites have been reported from this taxon since our last 
review, homoisopogon B-D (14, 18, 19), (3R)-2,3-dihydro-7-
hydroxy-5 -me thoxy-3 - (4 ′ -me thoxybenzy l ) -6 ,8 -
dimethyl-4H- chromen-4-one (39), 8-formylophiopogonanone 
B (42), ophiopogonanone G (61), homoisopogon A (62), 
(3R)-3-(1,3-benzodioxol-5-ylmethyl)-2,3-dihydro-7-
hydroxy-5-methoxy-6- methyl-4H-chromen-4-one (63), 
(3R)-3-(1,3-benzodioxol-5-ylmethyl)-2,3-dihydro-7-
hydroxy-5-methoxy-6,8-dimethyl-4H- chromen-4-one (70), 
ophiopogoside A (73), ophiopogoside B (75), 
4′-O-demethylophiopogonanone E (81), 5,7,2′,3′-tetrahy-
droxy-6-methyl-8-methoxy-3-(4′-methoxybenzyl)chroman-
4-one, (84), ophiopogonanone H (98), 6-formylophiopogonone 
B (128) 8-formyl-7-hydroxy-5,4′-dimethoxy-6-methylho-
moisoflavone (129), ophiopogonone D (130), and ophio-
pogonone E (131).22-28
For C. sappan, the native range is the Indian subcontinent 
to Indo-China. It has been introduced to Nigeria, the Congo, 
Mozambique, Tanzania, and Uganda in Africa (Accessed 
September 13, 2018 [http://www. plan tsof thew orld online. 
org/ taxon/ urn: lsid: ipni. org: names: 481889-1]). The heart 
wood of C. sappan is the most used part and studies have 
shown that the main homoisoflavonoid ingredient of the 
heartwood of this plant is brazilin (3), which is responsible 
for several of the observed biological activities, which 
include cytotoxic, antitumor, antimicrobial, antiviral, immu-
nostimulant, and other properties. This plant has been the 
subject of several studies which have resulted in the identifi-
cation of many new HIFs including the first report of a Δ3,4-
unsaturated homoisoflavan from a natural source (20), 
3′-deoxy-4-O-methylepisappanol (28), (3R,4S)-3,7-
d ihydroxy-3- (3 ʹ -me thoxy-4 ʹ -hydroxybenzy l ) -4 -
ethoxychroman (caesalpiniaphenol F, 29), 
(3S,4R)-3,7,2ʹ,3ʹ-tetrahydroxy-3,4-dihydro-9H-indeno[6,5 c]
chromene (caesalpiniaphenol E) (142),29 caesalpinophenols 
G (84) and H (146), (3R)-3,7-dihydroxy-3-(4′-hydroxy-3′-
methoxybenzyl)-chroman-4-one (85),30 7,10,11-trihy-
droxydracaenone (143), epicaesalpin J (144),31 caesappin A 
(145), and caesappin B (150).32
Novel Structures Containing the HIF Skeleton
Novel structures that have been reported during this period 
will be summarized hereunder. In the earlier review3 a few 
HIFs with attachment of sugar units were reported. A 
5-O-glucoside, 5-O-rutinoside, and a 5-O-neohesperoside 
were listed, which were linked to 3-hydroxy-3-benzylchro-
man-4-ones. These were isolated from Ornithogalum cauda-
tum. During the current review period a few more glycosides 
have been reported. Simple 7-O-glucosides (74 and 75) were 
reported from O. japonicus.26 Two disaccharide glycosides 
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of benzylchroman-4-ones (44 and 45) were also reported 
from Ledebouria floribunda.33 A slightly more complex gly-
coside, (3R)-5,7-dihydroxy-8-(2ʺ-O-veratroyl-β-d-
glucopyranosyl)-3-(4ʹ- hydroxyphenyl)-6-methylchro-
man-4-one (43) (Figure 3) has been reported from the 
Araliaceae plant Acanthopanax brachypus.34
Furthermore, a biogenetically intriguing set of 3 homoi-
soflavonoid glycosides (133, 134, and 135) (Figure 3) has 
been reported from Prunus domestica belonging to the 
Rosaceae family.35 What is distinct about these 3 compounds 
is the unique carbon framework which has a methyl substit-
uent at C-2, a Δ2,3-unsaturation, and glucosylation of a steri-
cally crowded C-4ʹ-hydroxyl group of ring β-propenoic acid, 
whose β-carbon is attached to C-6, is seen to extend further 
the homoisoflavonoid carbon framework. Further elabora-
tion takes place where esterification with propyl alcohol 
gives 134 and with hydroquinone 135. It is to be noted that 
these unusual glycosides are found in the 2 families, 
Araliaceae and Rosaceae, where HIFs are unknown or 
extremely rare. The compounds 133 to 135 showed potent 
inhibitory activity against α-glucosidase and this is further 
discussed in a later section on antidiabetic properties of 
HIFs.
Although prenylated and geranylated flavonoids are very 
common in certain families of plants, compounds 38, 40, and 
41 (Figure 4) are the first examples of prenylated HIFs. 
These unusual compounds were reported from the bulbs of 
L. floribunda.36
Zhao et al37 reported the isolation of the 3-benzyl-
chromen 20 (Figure 4) from C. sappan and observed that 
this may have been the first natural product possessing a 
double bond located at C-3 and C-4 of a homoisoflavan sys-
tem. In 2016 came a further report on the isolation of 3 more 
similar Δ3,4-unsaturated compounds, but with additional 
hydroxy and methoxy substituents38,39 from Caesalpina spi-
nosa and Herreria montevidensis, respectively. Interestingly, 
He et al also reported 2 more compounds 23 and 24 from the 
same plant, which contain a carbonyl group at C-2. This 
compound was identified as a 3-benzyl coumarin, although 
it can also be characterized as an oxidized homoisoflavo-
noid. The natural occurrence of 23 and 24 (Figure 4) has a 
special biogenetic significance and may indicate a new bio-
synthetic route to coumarins that have not been realized 
before.
In 2014 Wang and coworkers isolated caesappin A (145) 
together with caesappin B (146), where the latter is most 
probably the precursor of 146 (Wang et al., 2014).  These 
compounds are unusual in that there has been a rearrange-
ment of the carbon framework (cf. epihematoxylol B 147 
(Lin et al., 2014a)) for which these workers propose the 
mechanism depicted in Scheme 5 showing how they may be 
biosynthesized in the plant. Scheme 5. Biogenetic scheme to 
caesappin A (145).
Classification of HIFs
This report is prepared by following the classification of 
HIFs proposed in the 2007 review3 and carefully building on 
it to update the total number of HIFs that is known from 
natural sources to date. This will enable readers to consult 
the 2 reviews and get a full and broader coverage of the sub-
ject. Therefore, the HIFs are classified into 5 major groups A 
to E as restated below and depicted in Figure 5.
The first group, A (Table 1), is based on the 3-benzylfla-
van skeleton, with a new subclass containing Δ3,4-
unsaturation and 3,4-dioxygenation.
The second group, B (Table 2), consists of the 3-benzyl-
chroman-4-ones. The majority of the recently discovered 
HIFs belongs to this class. Also included in this section are 
Figure 3. Glycosylated HIFs.
Figure 4. Examples of unusual HIFs.
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the 3-hydroxy derivatives (Table 3), which are fewer, with 
just 2 compounds 102 and 103 having 9-hydroxy 
substituents.
Group C compounds have the Δ3,9 with either E or Z ste-
reochemistry at the Δ3,9-double bond and derivatives 
(Table 4). Many HIFs in this subgroup belong to the E series. 
The observation made in the previous review where the Δ2,33 
unsaturated HIFs were largely restricted to the genus 
Ophiopogon is repeated once again.24-26,28,35
Group D is the scillascillins (Table 5). Only 6 HIFs in this 
class (136-141) are reported in this period.
Group E contains the rearranged polycyclic HIFs 
(Figure 6). Ten HIFs (130-138) with 5 carbon skeletons have 
been reported from 2 species, C. sappan and Haematoxylon 
campechianumi.
Biological Activities of HIFs
Pharmacological Properties of Brazilin
A recent review6 has dealt with the pharmacological activi-
ties of the homoisoflavonoid brazilin. This review states: 
Brazilin is the safe natural compound having potential to 
develop as a medicinal compound with application in food, 
beverage, cosmetics and pharmaceutical industries to screen 
its clinical use in modern medicine but cautions that more 
studies are needed to evaluate the potential application of 
brazilin as preservative and coloring agent in food process-
ing industries. Brazilin is reported to have a high antioxidant 
property (IC50 8.8 µM) comparable with or better than 
(+)-catechin (10.2 µM). It has also been found to be effective 
against drug-resistant Gram-positive bacteria including 
MRSA, vancomycin-resistant enterococci, and 
multi-drug-resistant Burkholderia cepacian. Brazilin 
showed antibacterial activity with a Minimum inhibitory 
concentration of 0.50 mg/mL. The 50% inhibitory concen-
tration (IC50) for lipase inhibition was lowest for brazilin (6 
µM), which showed strong inhibition compared with chlor-
amphenicol (677 µM, positive control).80 Experimental evi-
dence is outlined in the Nirmal review supporting the 
beneficial hypoglycemic role of brazilin by enhancing glu-
cose metabolism in adipose tissue, by inhibiting protein 
kinase C and insulin receptors serine kinase, and by inducing 
glucose transport in isolated rat epididymal adipocytes, 
including details on its mechanism of action.6 The vasore-
laxing property of brazilin has also been documented. 
Brazilin relaxed phenylephirine-induced vasoconstriction 
and increased cGMP in isolated rat aorta. More recently, bra-
zilin is reported to increase the life span of the nematode 
worm Caenorhabditis elegans. The mean life of 12.3 ± 0.4 
days was increased to 14.5 ± 0.4 days when the worms were 
fed 100 µM brazilin.81
Antioxidant and Anti-Inflammatory Properties
The antioxidant and anti-inflammatory properties of several 
HIFs have been reported using the simple 2,2-diphe-
nyl-1-picrylhydrazyl (DPPH) method, the inhibition of nitric 
oxide (NO) or the suppression of inducible nitric oxide 
(iNOS) synthase, inhibiting prostaglandin (PGE2), interleu-
kin (IL)−1b production, etc. Ledebouria floribunda has been 
identified as a source of HIFs, some with prenyl and geranyl 
groups and others with glycosidic linkages.33,36 The 3 pre-
nylated and geranylated derivatives (38, 40, and 41) are the 
first reports of HIFs with triple (acetate, shikimate, and 
mevalonate) biosynthetic pathways. These were assessed for 
their DPPH scavenging properties (Table 6) and were found 
to be either stronger or equal to the usual reference antioxi-
dants like Butylated Hydroxytoluene (BHT) and Butylated 
hydroxyanisole (BHA). The expected activity due to the 
ortho dihydroxy groups is probably enhanced by other fac-
tors introduced by the prenyl and geranyl groups.
Calvo et al36 also reported HIFs with sugar groups 
attached to the C-7 phenolic group of ring A. Their antioxi-
dant properties have been assessed using both the DPPH 
scavenging as well as the β-carotene/linoleic acid system. 
The results showing strong antioxidant properties are shown 
in Table 6.
Hung et al26 investigated the effect of HIFs on the release 
of the inflammatory chemokine eotaxin, stimulated by IL-4 
and in combination with TNF-α in BEAS-2B cells, which 
mimics the in vivo conditions in bronchial allergic asthma. 
They investigated the ability of HIF ophiopogoside A (62), 
ophiopogoside B (63), and ophiopogonanone G (72) to reg-
ulate cytokine-induced eotaxin expression in the human 
bronchial epithelial cell line BEAS-2B. IL-4 stimulation (20 
ng/mL) of BEAS-2B cells for 48 hours increased eotaxin 
production from 10.7 to 60.5 pg/mL. The HIFs at 1.0, 5.0, 
10.0, and 25.0 µM significantly downregulated IL-4-induced 
eotaxin production in a dose-dependent manner. At a con-
centration of 25 µM, ophiopogoside A (62), ophiopogoside 
B (63), and ophiopogonanone G (69) reduced eotaxin pro-
duction to 30.8, 28.5, and 25.5 pg/mL, respectively. It was 
also shown that these compounds could inhibit eotaxin pro-
duction in the combination of IL-4 and TNF-α stimulation; 
the cells were pre-incubated with compounds 62 and 63 for 
2 hours and then activated with IL-4 (10 ng/mL) and TNF-α 
(10 ng/mL). The BEAS-2B cells produced 28.1 pg/mL 
Figure 5. The five groups (A-E) of homoisoflavoids.
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eotaxin in the resting stage, but, after stimulation, eotaxin 
production increased to 456.2 pg/mL
The anti-inflammatory properties of sappanone A (159) 
were assessed by measuring its ability to inhibit the produc-
tion of NO, PGE2, and IL-6, as well as the expression of 
iNOS, cyclooxygenase-2 (COX-2), and IL-6 in lipopolysac-
charide (LPS)-stimulated RAW 264.7 cells.83 These authors 
present evidence that leads to the conclusion that the anti-in-
flammatory activity of sappanone A occurs by activating the 
Nrf2/HO-1 pathway and by suppressing LPS-induced NF-κB 
activation. Their investigations have provided mechanistic 
details underlying the anti-inflammatory activities of sappa-
none A and suggest that this natural product may be useful 
for either the prevention or treatment of Nrf2- and/or NF-κB-
dependent pathological conditions, such as inflammatory 
diseases.
Antibacterial, Antiviral, and Antifungal Activities
An interesting study by Jeong et al45 presents the antiviral 
activities of closely related HIFs assessed against neuramin-
idases (NAs) on the surface of influenza viruses (A/PR/8/34 
[H1N1], A/Hong Kong/8/68 [H3N2], and A/Chicken/Korea/
MS96/96 [H9N2]) and confirmed by the positive control 
with oseltamivir (IC50 = 5.8 nM [H1N1], 5.6 nM [H3N2], 
and 1.2 nM [H9N2]). The HIFs included in these studies 
were brazilin (3), sappanone B (6), 3-deoxysappanone B (5), 




droxy-3-benzyl-2H-chromene, and brazilin (3). Brazilin and 
sappanone A (159) were the most active with IC50 (µM) 
 
Table 1. Group A: 3-Benzylflavan (20-22 and 26-30), Δ3,4- (13-19 and 23-26) and 3,4-dihydroxy (31) derivatives
No 5 6 7 8 2ʹ 3ʹ 4ʹ 5ʹ Source [Family]a, part of plant References
13   OMe    OMe  +30 (3R) H. montevidensis [A], root 39
14   OMe  OH  OMe  +23 O. japonicus [A], tuber 22
15  OH  OMe   OH  +41.5. 3R Soymida febrifuga [M], bark 40
16 OMe Me OMe    OH  +50.7 (3R) H. montevidensis [A], root 39
17 OMe Me OH    OH  +53.8 (3R) H. montevidensis [A], root 39
18  Me OMe  OH  OMe  +18 O. japonicus [A], tuber 22
19  Me OH   OCH2O   +12.5 O. japonicus [A], tuber
22
20   OH    OH  - C. spinosa [F], twigs and leaves 38
21   OH   OH OH  - C. sappan [F], heartwood 37
22   OH OMe   OH  - H. montevidensis [A], root 39
23   OH     OH - Anemarrhena asphodeloides [A], root 41
24   OMe     OH - C. spinosa [F], twigs and leaves 38
25  OMe OH    OH  - S. febrifuga [M], bark 40
26  OH OH   OH OH  - O. japonicus [PP], aerial 42
No 3 4 7 8 2ʹ 3ʹ 4ʹ 5ʹ Mp, [α]D, R/S Source [Family]
a, part of plant References
31         - C. sappan [A], heartwood 45
aA,  Araliaceae; F,  Fabaceae; Po,  Polygonaceae; Pt,  Portulacaceae;  M,  Meliaceae; PP,  Polypodiaceae.





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































values of 0.2 and 0.7 against [H1N1], 0.3 and 1.1 against 
[H3N2], and 0.4 and 1.0 for [H9N2]. These 2 were in a class 
of their own and were singled out as lead compounds with 
high potency against 3 viral NAs. The study also suggested 
that the α, β-unsaturated group of sappanone A (159) 
(Figure 7) was critical for activity as the others without this 
functional group showed higher IC50 values in the range 63 
to 204 µM. A further observation was also that the 4R HIF 
4-O-methylepisappanol was more active with IC50 values of 
63.2 µM [H1N1, H3N2] and 42.8 µM for [H9N2] than the 4S 
isomers 4-O-methylsappanol (8) with IC50s of 94.5 µM 
[H1N1], 134.7 [H3N2], and 99.6 µM for [H9N2]. Similar 
values were obtained for sappanol and episappanol.29 Cruz et 
al84 tested various compounds, including brazilin (3) and 
hematoxylin (161), isolated from the methanolic extract of 
Haematoxylon brasiletto against 12 bacteria and the fungus 
Candida albicans, but found these 2 compounds only weakly 
active against the tested organisms.
 
Table 4. Group C: Δ3,9-Z (105-106), E (107-127), and Δ2,3-Unsaturated (133-135) -3-Benzylchroman-4-Ones.
105 OH OH OMe - Caesalpinia diigyna [F], root 71
106 OH OMe OMe - Caesalpinia millettii [F], stem 72
107 OMe OMe 130°C to 132°C Caesalpinia pulcherima [F], whole 73
108 OH OMe OH 146°C P. oleracea [Po], aerial 48
109 OH O-CH2O - C. pulcherima [F], aerial
74
110 OMe O-CH2O - C. pulcherima [F], aerial
74
111 OH OH OMe - C. pulcherima [F], aerial 74
112 OMe OMe OMe - C. pulcherima [F], aerial 74
113 OH OGlc OH −67.4 P. odoratum [A], root 60
114 OH Me OH Me OH 217°C to 218°C P. odoratum [A], root 60
115 OH OH OH OH - Ledebouria ovatifolia [A], bulb 75
116 OH OMe OH OH - Massonia biolia [A], bulb 53
117 OH OMe OMe OH - B. eigii [A], bulb 63
118 OH OMe OMe OMe 202°C to 204°C C. pulcherima [F], whole 73
119 OMe OMe OH OMe 168°C to 170°C C. pulcherima [F], aerial 74
120 OH Me OH Me OH OH 233°C to 234°C P. odoratum [A], rhizome 76
121 OH OH OH Me OH - Eucomis pallidiflora subsp pole-evansii [A], bulb 77
122 OH OH OH OH OH - C. sappan [F], heartwood 30
123 OH OMe OMe OH OH - B. eigii [A], bulb 63
124 OH OH OH OH OMe - R. campanulatus [A], bulb 55
125 OH Me OH OH - A. asphodeloides [A], rhizome 41
126 OMe Me OMe OH OH OH - S. persica [A], bulb 78
127 OH Me OH OMe OH OH 250°C to 251°C P. odoratum [A], rhizome 73
128 OH CHO OH Me OMe - O. japonicus [A], root 25
129 OMe Me OH CHO OMe - O. japonicas [A], root 25
130 OH Me OH OH OH - O. japonicus [A], root 24
131 OH Me OH OMe OH OH - O. japonicus [A], root 28
132 OH OH OH OH OH - C. sappan [F], heartwood 30
133 See structure R = H +14.5 P. domestica [R] shoot 35
134 See Structure R = Propyl +16.0 P. domestica [R] shoot 35
135 See structure R = p-hydroxyphenyl +24.0 P. domestica [R] shoot 35
aA, Asparagaceae; F, Fabaceae; Po, Polygonaceae; R, Rosaceae.
Abegaz and Kinfe 11
Antihyperglycemic Properties
The hypoglycemic properties of HIFs have been assessed in 
terms of their ability to modulate the insulin receptor, lower 
blood glucose, and regulate the levels of various kinases 
(protein kinase C, phosphotidylinositol 3-kinase, pyruvate 
kinase, and 6-phosphofructo-2 kinase), which are involved 
in the gluconeogenesis and glycolytic pathways and glucose 
transport.60
The 2 protein components of the glucose absorption sys-
tem of the intestine are the sodium-dependent glucose trans-
porter-1 (SGLT1), and glucose transporter (GLUT). Several 
HIFs have been evaluated for their ability to either activate 
adenosine monophosphate-activated protein kinase (AMPK) 
or to inhibit the activity of the GLUT transmembrane carri-
ers.85,86 Adenosine monophosphate protein kinase activators 
are potential therapeutic candidates for the treatment of dia-
betes as they can increase the uptake of glucose via mem-
brane translocation of GLUT 4. Six previously known HIFs 
from the rhizomes of P. odoratum were evaluated for their 
ability to activate AMPK, and 3 of them (153, 154, and 157) 
exhibited significant activation effects. 153, 154, and 157 
(Figure 8) also emerged as the most effective of 19 other 
HIFs as novel potent GLUT2 inhibitors. In addition, they 
also demonstrated synergistic inhibition of glucose transport 
when combined with previously identified SGLT1 specific 
antagonists.85
In another earlier study87 2 of the HIFs, 155 and 157, were 
identified as the active constituents of P. odoratum acting as 
peroxisome proliferator-activator receptor agonists 
(PPARAs) by binding to PPARc ligand-binding pocket. The 
authors caution the herbal use of the plant against side effects 
resulting from PPARC activation.
The 3 esters, prunuside A to C, with a rather unusual sub-
stitution and carbon framework, were obtained from the 
shoots of the Rosaceae plant, P. domestica. The source of 
these prunusides is a tree whose fruits are edible and used to 
lower blood sugar in India and Pakistan. The HIFs (133-134) 
were assayed for α-glucosidase inhibitory activity.35 It is 
known that α-glucosidase inhibitors, such as acarbose, migli-
tol, and voglibose, can reduce the rate of cleavage of glucose 
from dietary carbohydrates and hence suppress postprandial 
hyperglycemia. Accordingly, Kosar et al35 assessed the 
α-glucosidase inhibitory activity of 133 to 134 and found the 
IC50 ± SEM (μM) to be: 216.6 ± 0.027, 268.4 ± 0.047, and 
203.6 ± 1.700, respectively. The value obtained for the 
 
Table 5. Group D: Scillascillins: Compounds 136 to 141.
No 5 6 7 8 2ʹ 3ʹ 4ʹ 5ʹ Mp; [α]D Source [Family],
a part of plant References
136 OH Me OH OH OMe +6.96 B. elegans [A], bulb 57
137 OH  OH OH OMe OMe +65.6 S. scilloides [A], bulb 62
138 OH  OMe OH OMe OH +32 Drmiopsis barteri [A], bulb 79
139 OH  OMe OH OMe OMe +40 Ledebouria socialis [A] bulb 75
140 OH  OH OMe OMe OMe 197°C to 199°C; D. barteri [A], bulb 79
141 OH  OMe OMe OMe OMe +55.0 D. barteri [A], bulb 79
aA = Asparagaceae.
Figure 6. Group E: Rearranged HIFs: Compounds 142 to 150.
Table 6. Antioxidant Data of HIFs Using DPPH Radical 




IC50 (μg/mL) System B References
2 3.11 57.0 33
3 8.8 - 82
6 14.5 - 82
38 112 - 36
40 23.2 - 36
41 28.7 - 36
44 212.4 26.0 36
45 273.1 11.4 36
151 84.3 41.9 36
152 39.4 64.5 36




positive control, deoxynojirimycin, used in the study was 
281.3 ± 2.8. All the esters were more active than the control, 
particularly 134, which is probably due to the pharmacoph-
oric contribution of the hydroquinone moiety.
Adenosine monophosphate protein kinase activation is 
known to affect glucose and lipid metabolism, gene expres-
sion, and protein synthesis. Two out of 6 HIFs isolated from 
the rhizomes of P. odoratum, (3R)-5,7-dihydroxyl-6-methyl-
8-methoxyl-3-(4ʹ-hydroxybenzyl)-chroman-4-one and (3R)-
5,7-dihydroxyl-6,8-dimethyl-3-(4ʹ-hydroxybenzyl)-
chroman-4-one were found to have significant activation 
effects.86
Cytotoxic Activities
The cytotoxicity of HIFs on various cell lines, including 
tumor cells has been documented.
Uesawa et al88 undertook a SUGITA3 quantitative struc-
ture-activity relationships of 16 HIFs (3-benzylidinechroma-
nones) and concluded that those 3-benzylidenechromanone 
derivatives that have a methoxy group at position C-7 of the 
chromanone ring and either hydroxyl or methoxy group at 
C-4ʹ of the B ring showed relatively higher tumor-specificity 
values, exceeding those of doxorubicin and 5-fluorouracil. 
The paper concluded by pointing out that molecular shape, 
size and polarization are useful indicators for the evaluation 
of tumor specificity of this class of compounds. Compound 
132 (caesalpiniaphenol G) isolated from the heartwood of 
Vietnamese C. sappan contains a hydroxyl group at C-7 and 
4 such groups in ring B.30 It was isolated together with the 
highly modified caesalpiniaphenol and structurally rear-
ranged compound caesalpiniaphenol H (148). Both com-
pounds showed potent inhibitory activity against HL-60 
cancer cell lines with respective IC50 values of 16.7 and 22.5 
µg/mL. Treating HL-60 cells with 132 resulted in inhibition 
of growth and introduction of apoptosis.
The anticancer potential of intricatinol (160) (Figure 9) in 
combination with the known anticancer drug cisplatin in 
nonsmall-cell lung carcinoma (A549 cells) was demon-
strated by the observed apoptosis showing DNA fragmenta-
tion and Annexin V positive cells. It was shown that treatment 
with the HIFs alone reduced the viability of the A549 cells in 
a dose-dependent manner, as reported by Singh et al89
In studying the roles of protein tyrosine kinase (PTK) 
inhibitors for cancer chemoprevention, Lin et al90,91,108 found 
that hematoxylin (161) was a “most remarkable” c-Src inhib-
itor in an orthogonal compound-mixing library of 32 200 
compounds, and that the inhibition was associated with PTK 
phosphorylation and subsequent downstream signaling path-
ways. Subsequently,92 brazilein, an oxidized form of hema-
toxylin, was found to inhibit adipocyte differentiation, 
inducing apoptosis through capsase-3 activity.
In a recent study Yang et al93 investigated the antitumor 
properties of protosappanin B (134). Both in vitro, by trypan 
blue exclusion and MTT assays, and in vivo, on H22 mouse 
liver cancer cells invasion and the survival of tumor-bearing 
mice were investigated. In both cases, they found that pro-
tosappanin B (134) exerts marked antitumor effects.
Antiproliferative activity guided investigation of the 
South African plant U. depressa led to the isolation of 6 new 
HIFs 33, 60, 83, 94, 97, 102 and all except 33 were shown to 
possess good antiproliferative activity against the A2780 
ovarian cancer, A2058 melanoma, and H522-T1 human non-
small-cell lung cancer cells, and urgineanin A (97) had sub-
micromolar activity against all 3 cell lines.46
The finding that 5,7-dihydroxy-3-(4ʹ-hydroxy-3ʹ-me-
thoxybenzyl)-6-methoxyhomoisoflavanone (cremastrone) 
possesses antiangiogenic activity both in vitro and in vivo 
and was a potent inhibitor of the proliferation of human 
umbilical vein endothelial cells,94 prompted further work to 
identify other natural HIFs and their derivatives which may 
be developed as small molecule therapeutic agents.95,96 
Among natural HIFs methylophiopogonanone A (9) and B 
have been identified as potentially significant hits. The for-
mer (9) has been shown to protect against cerebral ischemia/
reperfusion injury and attenuates blood-brain barrier disrup-
tion in vitro.97
Synthesis of Naturally Occurring HIFs
The commonly employed methodologies for the construc-
tion of the homoisoflavonoid scaffolds can be categorized 
into 2 general groups:
Figure 9. Cytotoxic HIFs.Figure 7. Example of antiviral HIF.
Figure 8. Examples of antihyperglycemic HIFs.
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Scheme 1. General protocols for the synthesis of HIFs.
Scheme 2. BnBr, NaI, acetone, 80°C, 5 hours, 80%.
1. Aldol condensation of pre-prepared chroman-4-ones 
with aryl aldehydes (Scheme 1a) provides HIFs (165) 
with an exoΔ3,9 double bond. Furthermore, the homoi-
soflavonoid isomer 166 with the endoΔ2,3 double bond 
can be prepared via migration of the exo double bond 
by treatment with a base or rhodium catalysts;
2. Acid catalyzed cyclization of dihydrochalcones 167, 
in the presence of one-carbon extension reagents, 
such as CH3SO2Cl//DMF, HCO2Et/Na, 2,4,6-tri-
chloro-1,3,5-triazine/DMF, and HC(OEt)3/HClO4, 
yields HIFs 166 with the endoΔ2,3 double bond 
(Scheme 1b).
Since our last review, few novel synthetic methodologies 
have been developed for the construction of the homoisofla-
vone scaffolds. The cyclobenzylation reaction of (E)-3-
(dimethylamino)-1-(2-hydroxy-4,5-methylenedioxy-
phenyl)prop-2-en-1-one 168 and benzyl bromide at 80°C in 
the presence of NaI is a recent methodology for the synthesis 
of homoisoflavonoid derivatives 172 (Scheme 2).98 The 
reaction is proposed to proceed as shown in Scheme 2 and 
involves intramolecular cyclization followed by benzylation 
of the resulting enolate 170 and subsequent elimination of 
the dimethyl amine group to provide the homoisoflavonoid 
172.
In a serendipitous discovery, Lee and co-workers devel-
oped an interesting ruthenium-catalyzed synthesis of 2-aryl-
homo-isoflavonoid 179 scaffolds by reacting salicylaldehyde 
and alkynoic acids via C-H activation, as depicted in Scheme 
6.99 The reaction is proposed to proceed via initial formation 
of chalcone 175 that undergoes intramolecular cyclization to 
provide the flavonoid intermediate 176.
Aldol condensation between the flavonoid 176 and an 
additional salicylaldehyde provides homoisoflavonoid 178 
with an exoΔ3,9 double bond that rearranges to the endoΔ2,3 
isomer 179. However, the rearrangement reaction from the 
exoΔ3,9 double bond to the endoΔ2,3 double bond was uncon-
trollable to prepare selectively either the homoisoflavonoid 
178 or 179 as desired. Bhagavathy and co-workers reported 
an interesting tandem thermal [1,3]-[1,3]-para and [1,3]-
ortho- rearrangement of chromone-3-ylmethyl aryl ethers 
for the synthesis of homoisoflavonoids 181 and 182 as shown 
in Scheme 7.100 Despite its simplicity and generality, the pro-
tocol has not been applied to the synthesis of natural 
homoisoflavonoids.
The major advance made in the synthesis of HIFs post 
2007 is the focus on asymmetric synthesis. Yu et al, for 
instance, reported the asymmetric synthesis of several sap-
panin-type natural HIFs (190 to  194)101 using Evans’ chiral 
auxiliaries 183 and 195.102 The use of Evans’ chiral auxiliary 
183 led to the synthesis of homoisoflavan 190 in >99% ee via 
aldol, intramolecular cyclization and deoxygenation reac-
tions as key steps, as shown in Scheme 3. By analogy, using 
Evans’ chiral auxiliary 195, the synthesis of enantiomer 194 
was achieved in >099% ee (Scheme 3). Oxidation of 190 
using DDQ gave 191, while demethylation of 190 afforded 
192 and upon treatment with DDQ provided homoisoflava-
none 193 (Scheme 3) (192 and 193 have been reported from 
commercial Dragon’s blood Dracaena draco and D. 
cambodiana.103)
By exploiting the versatility of Sharpless dihydroxylation 
and epoxidation reactions, a number of sappanone-type nat-
ural HIFs have been prepared. This is demonstrated by Kim 
and co-workers who successfully synthesized (+)-urgineanin 
A-D and (−)-urgineanin A (196a-d) (196a-d were isolated 
from the South African plant U. depressa.46), as depicted in 
Scheme 8.104 Palladium-catalyzed allylic arylation of 197 
with arylboronic acids provided coupled product 198. 
Asymmetric dihydroxylation using (DHQ)2PHAL, followed 
by a regioselective oxidation led to the preparation of 
(+)-urgineanin A-D (196a-c) while the use of (DHQD)2PHAL 
as a dihydroxylating agent afforded (−)-urgineanin A (196d).
Similarly, by changing the substituents at the phosphorus 
atom of enol phosphates 201, synthesis of enantiopure (R)-
(+)-eucomol 202 and (S)-(−)-eucomol 203 (202/203 was first 
isolated from the bulbs of Eucomis bicolor Bak.105) was 
achieved via asymmetric dihydroxylation as shown in 
Scheme 9.103
In addition to asymmetric dihydroxylation strategies for 
the synthesis of enantiopure sappanones, an enantioselective 
cyclization protocol has also been reported. Takikawa and 
Suzuki designed and synthesized a modified Rovis catalyst 
204, a chiral triazolium salt that possesses a strongly elec-
tron-withdrawing group and applied it in the enantioselec-
tive benzoin cyclization of suitably prepared keto-aldehydes 
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205 for the preparation of (+)-sappanone B 6 (Scheme 4).107 
The presence of the strongly electron-withdrawing substitu-
ent (–CF3) on the aromatic ring of the triazolium salt sup-
presses enolization that leads to formation of side products 
via aldol reactions. This is due to the ease with which the 
hydrogen can be abstracted to generate a carbene catalyst by 
the weaker base, Et3N, which is not capable of enolizing the 
substrate. Furthermore, the generated carbene is less basic to 
enolize the keto-aldehyde 205.
The epoxidation and dihydroxylation reactions have been 
also instrumental in the total synthesis of (±)-brazilein, 
(±)-brazilin, and (±)-brazilane.108,109 Zhang and co-workers 
utilized asymmetric Sharpless dihydroxylation reaction for 
the enantioselective synthesis of (+)-brazilin (3), (−)-brazil-
ein (162), and (+)-brazilide A (214) from a common starting 
material, as shown in Scheme 10.110 Accordingly, coupling 
of indene 207 and phenol 208, followed by asymmetric dihy-
droxylation led to the formation of diol 210 in 81% ee. Acid 
catalyzed intramolecular cyclization and deprotection of the 
benzoate protecting group afforded the key intermediate tet-
racyclic 211. Demethylation of 211 provided (+)-brazilin (3). 
DIB-mediated oxidation of (+)-brazilin (3) gave (−)-brazil-
ein (162). Further manipulation of 211 provided 212 that 
underwent diastereoselective epoxidation to form epoxide 
213. Lactonization of epoxide 213 afforded (+)-brazilide A 
(214) in 82% yield.
In conclusion, HIFs are now recognized as an important 
subclass of flavonoids. They display broad structural diver-
sity and biological properties. They occur principally in 2 
plant families, Asparagaceae and Fabaceae, and several gen-
era including Ophiopogon, Caesalpinia, Polygonatum, 
Ledebouria, Belevalia, Dracaena, Hematoxylon, Liriope, 
Portulaca, Scilla, Pseudoprospera, and Urginea. Many spe-
cies belonging to these genera are important ingredients in 
many Chinese, Indian, Japanese, and other countries’ tradi-
tional medicine. HIFs are the major bioactive constituents of 
the popular medicinal plants O. japonicus,7 C. sappan,6 and 
of Dragon’s blood (Dracanea cinnabari).8 Ophiopogon 
Scheme 5. Biogenetic scheme to caesappin A (145).
Scheme 6. [Ru(p-cymene)Cl2]2 (2.5 mol %), CsOAc, DMSO, 
120°C, 12 hours, 64% to 82%.
Scheme 3. (i) TiCl4, (+)-sparteine, DCM, 0°C, 2 hours, 83%; (ii) 
Pd/C, EtOAc, rt, 5 hours, 95%; (iii) TiCl4, TMEDA, DCM, −20°C, 
2 hours, 62%; (iv) NaBH4, THF/H2O, 5 hours, 86%; (v) p-TsCl, n-
Bu2SnO, DMAP, Et3N, MeCN, rt, 3 hours, 84%; (vi) n-Bu4NF, THF, 
rt, 30 minutes, 92%; (vii) Ac2O, Et3N, DMAP, DCM, rt, 30 minutes, 
94%; (viii) Et3SiH, CF3CO2H, DCM, 0°C, 30 minutes, 88%; (ix) 
K2CO3, MeOH, rt, 30 minutes, 92%; (x) 2,3-dichloro-5,6-dicyano-
1,4-benzoquinone (DDQ), dioxane, H2O, rt, 30 minutes, 74%; (xi) 
BBr3, CH2Cl2, rt, 1 hour, 89%; (xii) DDQ, dioxane, H2O, rt, 30 
minutes, 57%.
Scheme 4. (i) cat. (15 mol %), Et3N, toluene, rt, 12 hours, 92%, 
95% ee; (ii) NaSC12H25, DMF, 80°C, 5 hours, 92%; (iii) BBr3, DCM, 
0°C, 0.5 hour, 85%.
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japonicus alone has yielded more than 38 HIFs,7 more than 
any other species, followed by Caesalpinia, Polygonatum, 
and Ledebouria species. Homoisoflavonoids have been 
shown to possess a wide range of pharmacological properties 
including antimicrobial, antimutagenic, antioxidant, immu-
nomodulatory, cytotoxic, antiangiogenic, anti-inflammatory, 
antiphotoaging, hypoglycemic, vasorelaxant, hepatoprotec-
tive, and antiacne activities. Brazilin (3) is the major and 
most biologically active of the 4 HIFs found in the heart-
wood of C. sappan.6 The folkloric uses of brazilin include 
antioxidant, antibacterial, anti-inflammatory, antiphotoa-
ging, hypoglycemic, vasorelaxant, hepatoprotective, and 
antiacne applications. The scientific evidence generated for 
brazilin strongly suggests its potential to be developed as a 
medicinal compound with application in the food, beverage, 
cosmetics, and pharmaceutical industries. Brazilin may also 
have applications as a preservative and coloring agent in the 
food processing industries. Some of the significant pharma-
cological data generated during the current review period 
include those of brazilin (3), sappanone B (6),80 ledebourin B 
(40), and ledebourin C (41)36 as antioxidants; sappanone A 
(159),83 ophiopogoside A (62), ophiopogoside B (63), and 
ophiopogonanone G (69)26 for their anti-inflammatory prop-
erties, and brazilin (3) and sappanone A (159) for their 
exceptional antiviral potencies29; HIFs 155 and 157,87 and 
133 to 13435 for their potential application as hypoglycemic 
agents; and methylophiopogonanone A (9),86 urgineanin A 
(97),46 protosappanin B (134),93 intricatinol (160),89 and 
hematoxylin (161)90 for their cytotoxic and tumor-inhibiting 
applications. The increasing importance of HIFs has also 
raised the interest of synthetic organic and medicinal chem-
ists. Both the earlier3 and the current reviews include various 
synthetic methodologies for the total synthesis of natural 
HIFs, as well as their derivatives. The development of asym-
metric synthesis, transition metal catalyzed coupling reac-
tions as well as H-activation synthetic methodologies is less 
explored for the synthesis of HIF.
Acknowledgments
This paper was written during B.M.A.’s 1-month stay (September 
2018) at the Stellenbosch Institute for Advanced Study (STIAS). 
B.M.A. is grateful to the leaders of this enabling institution and the 
staff who have been very gracious and helpful. Research Centre 
for Synthesis and Catalysis of the Department of Chemistry at 
UJ and the National Research Foundation (NRF)-DST are also 
acknowledged for financial support.
Scheme 7. Ph2O, Cs2CO3, reflux, 65% to 84%.
Scheme 8. (i) ArB(OH)2, Pd(PPh3)4, K3PO4, THF, 150°C; (ii) 
OsO4, (DHQ)2PHAL, K3Fe(CN)6, K2CO3, MeSO2NH2, 0°C; (iii) 
IBX; (iv) OsO4, (DHQD)2PHAL, K3Fe(CN)6, K2CO3, MeSO2NH2, 
0°C.
Scheme 9. (DHQD)2PHAL, OsO4, CH3SO2NH2, K3Fe(CN)6, 
K2CO3, 
tBuOH/H2O, 0°C.
Scheme 10. (i) DEAD, Ph3P, THF, −78°C, 60%; (ii) AD-mix-b, 
OsO4, MeSO2NH2, t-BuOH/H2O/DCM, 3 days, 85%, 81% ee; (iii) 
PPTS, toluene, 90°C, 80%; (iv) LiOH, THF/MeOH, 67%, 99.8% ee; 
(v) BBr3, DCM, 81%; (vi) PhI(OAc)2, THF, 0°C, 76%; (vii) m-CPBA, 
32°C, 3 days, DCM, 22%; (viii) a. BF3·Et2O, DCM; b. 65% H2SO4, 
AcOH, 110°C, 82%.
Natural Product Communications16
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect 
to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support 
for the research, authorship, and/or publication of this article: 
This article was financially supported by the Research Centre for 
Synthesis and Catalysis of the Department of Chemistry at UJ and 
the National Research Foundation (NRF)-DST.
References
 1. Dewick PM. Biosynthesis of the 3-benzylchroman-4-one 
eucomin. J Chem Soc Chem Commun. 1973;13(13):438-439.
 2. Dewick PM. Biosynthesis of the 3-benzylchroman-
4-one eucomin in Eucomis bicolor. Phytochemistry. 
1975;14(4):983-988.
 3. Abegaz BM, Mutanyatta-Comar J, Nindi M. Naturally 
occurring homoisoflavonoids: phytochemistry, 
biological activities and synthesis. Nat Prod Commun. 
2007;2(4):475-498.
 4. Du Toit K, Drewes SE, Bodenstein J. The chemical 
structures, plant origins, ethnobotany and biological 
activities of homoisoflavanones. Nat Prod Res. 
2010;24(5):457-490.
 5. Lin L-G, Liu Q-Y, Ye Y. Naturally occurring 
homoisoflavonoids and their pharmacological activities. 
Planta Med. 2014;80(13):1053-1066.
 6. Nirmal NP, Rajput MS, Prasad R, Ahmad M. 
Brazilin from Caesalpinia sappan heartwood and its 
pharmacological activities: a review. Asian Pac J Trop Med. 
2015;8(6):421-430.
 7. Chen M-H, Chen X-J, Wang M, Lin L-G, Wang Y-T. 
Ophiopogon japonicus—a phytochemical, ethnomedicinal 
and pharmacological review. J Ethnopharmacol. 
2016;181:193-213.
 8. Gupta D, Bleakley B, Gupta RK. Dragon's blood: botany, 
chemistry and therapeutic uses. J Ethnopharmacol. 
2008;115(3):361-380.
 9. Zhu Y, Zhang P, Yu H, Li J, Wang M-W, Zhao W. Anti- 
Helicobacter pylori and thrombin inhibitory components 
from Chinese Dragon’s blood, Dracaena cochinchinensis. J 
Nat Prod. 2007;70(10):1570-1577.
 10. Hu L, Wang F-F, Wang X-H, Yang Q-S, Xiong Y, Liu 
W-X. Phytoconstituents from the leaves of Dracaena 
cochinchinensis (Lour.) S. C. Chen. Biochem Syst Ecol. 
2015;63:1-5.
 11. Xu X, Cheng K, Cheng W, Zhou T, Jiang M, Xu J. 
Isolation and characterization of homoisoflavonoids from 
Dracaena cochinchinensis and their osteogenic activities 
in mouse mesenchymal stem cells. J Pharm Biomed Anal. 
2016;129:466-472.
 12. Xu P, Guan S, Feng R, Tang R, Guo D. Separation of four 
homoisoflavonoids from Caesalpinia sappan by high-
speed counter-current chromatography. Phytochem Anal. 
2012;23(3):228-231.
 13. Ma C, Li G, Zhang J, Zheng Q, Fan X, Wang Z. An efficient 
combination of supercritical fluid extraction and high-
speed counter-current chromatography to extract and purify 
homoisoflavonoids from Ophiopogon japonicus (Thunb.) 
Ker-Gawler. J Sep Sci. 2009;32(11):1949-1956.
 14. Uddin GM, Kim CY, Chung D, Kim K-A, Jung SH. One-
step isolation of sappanol and brazilin from Caesalpinia 
sappan and their effects on oxidative stress-induced retinal 
death. BMB Rep. 2015;48(5):289-294.
 15. Sievänen E, Toušek J, Lunerová K, et al. Structural studies 
of homoisoflavonoids: NMR spectroscopy, X-ray diffraction, 
and theoretical calculations. J Mol Struct. 2010;979(1-
3):172-179.
 16. Hu X-R, Chou G-X, Zhang C-G. Flavonoids, alkaloids 
from the seeds of Crotalaria pallida and their cytotoxicity 
and anti-inflammatory activities. Phytochemistry. 
2017;143:64-71.
 17. Pescitelli G, Bruhn T. Good computational practice in 
the assignment of absolute configurations by TDDFT 
calculations of ECD spectra. Chirality. 2016;28(6):466-474.
 18. Batista JM, Wang B, Castelli MV, Blanch EW, López 
SN. Absolute configuration assignment of an unusual 
homoisoflavanone from Polygonum ferrugineum using 
a combination of chiroptical methods. Tetrahedron Lett. 
2015;56(44):6142-6144.
 19. López SN, Sierra MG, Gattuso SJ, Furlán RL, Zacchino 
SA. An unusual homoisoflavanone and a structurally-
related dihydrochalcone from Polygonum ferrugineum 
(Polygonaceae). Phytochemistry. 2006;67(19):2152-2158.
 20. Midiwo JO, Omoto FM, Yenesew A, Akala HM, Wangui 
J, Liyala P. The first 9-hydroxyhomoisoflavanone, and 
antiplasmodial chalcones, from the aerial exudates of 
Polygonum senegalense. Arkivoc. 2007;ix:21-27.
 21. Dzoyem JP, Kuete AHL, Kuete V, et al. Cytotoxicity 
and antimicrobial activity of the methanol extract and 
compounds from Polygonum limbatum. Planta Med. 
2012;78(8):787-792.
 22. Dang NH, Chung ND, Tuan HM, Hiep NT, Dat NT. 
Cytotoxic homoisoflavonoids from Ophiopogon japonicus 
tubers. Chem Pharm Bull. 2017;65(2):204-207.
 23. Wang Y, Xu J, Zhang L, Qu H. Three new 
homoisoflavanones from Ophiopogon japonicus Ker-Gawler 
(Liliaceae). Helv Chim Acta. 2010;93(5):980-984.
 24. Duan C-L, Kang Z-Y, Lin C-R, Jiang Y, Liu J-X, Tu P-F. 
Two new homoisoflavonoids from the fibrous roots of 
Ophiopogon japonicus (Thunb.) Ker-Gawl. J Asian Nat Prod 
Res. 2009;11(10):876-879.
 25. Zhou C-X, Zou L, Mo J-X, et al. Homoisoflavonoids 
from Ophiopogon japonicus. Helv Chim Acta. 
2013;96(7):1397-1405.
Abegaz and Kinfe 17
 26. Hung TM, Thu CV, Dat NT, et al. Homoisoflavonoid 
derivatives from the roots of Ophiopogon japonicus and their 
in vitro anti-inflammation activity. Bioorg Med Chem Lett. 
2010;20(8):2412-2416.
 27. Zhao J-W, Chen D-S, Deng C-S, Wang Q, Zhu W, Lin L. 
Evaluation of anti-inflammatory activity of compounds 
isolated from the rhizome of Ophiopogon japonicus. BMC 
Complement Altern Med. 2017;17(1):1-12.
 28. Li N, Zhang J-Y, Zeng K-W, Zhang L, Che Y-Y, Tu 
P-F. Anti-inflammatory homoisoflavonoids from the 
tuberous roots of Ophiopogon japonicus. Fitoterapia. 
2012;83(6):1042-1045.
 29. Min BS, Cuong TD, Hung TM, Min BK, Shin BS, Woo MH. 
Compounds from the heartwood of Caesalpinia sappan and 
their anti-inflammatory activity. Bioorg Med Chem Lett. 
2012;22(24):7436-7439.
 30. Hung TM, Hai NX, Nhan NT, et al. Cytotoxic 
activity of new phenolic compounds from Vietnamese 
Caesalpinia sappan. Biosci Biotechnol Biochem. 
2013;77(12):2378-2382.
 31. Zhao M-B, Li J, Shi S-P, et al. Two new phenolic compounds 
from the heartwood of Caesalpinia sappan L. Molecules. 
2014;19(1):1-8.
 32. Wang Z, Sun J-B, Qu W, Guan F-Q, Li L-Z, Liang J-
Y. Caesappin A and B, two novel protosappanins from 
Caesalpinia sappan L. Fitoterapia. 2014;92:280-284.
 33. Calvo MI. Homoisoflavanones from Ledebouria floribunda. 
Fitoterapia. 2009;80(2):96-101.
 34. H-B H, Zhu J-H. Flavonoid constituents from the 
roots of Acanthopanax brachypus. Chem Pharm Bull. 
2011;59(1):135-139.
 35. Kosar S, Fatima I, Mahmood A, et al. Purunusides A-C, 
α-glucosidase inhibitory homoisoflavone glucosides from 
Prunus domestica. Arch Pharm Res. 2009;32(12): 
1705-1710.
 36. Calvo MI. Three new homoisoflavanones from the bulbs of 
Ledebouria floribunda. Fitoterapia. 2009;80(7):394-398.
 37. Zhao H, Bai H, Wang Y, Li W, Koike K. A new 
homoisoflavan from Caesalpinia sappan. J Nat Med. 
2008;62(3):325-327.
 38. DY H, YP L, Tang HB, et al. Phenolic compounds from the 
twigs and leaves of Tara (Caesalpinia spinosa). J Asian Nat 
Prod Res. 2016;18(4):334-338.
 39. Dutra-Behrens M, Schmeda-Hirschmann G. New 
homoisoflavanes, a new alkaloid and spirostane steroids 
from the roots of Herreria montevidensis Klotzsch ex 
Griseb. (Herreriaceae. Molecules. 2016;21(11):E1589.
 40. Awale S, Miyamoto T, Linn TZ, et al. Cytotoxic constituents 
of Soymida febrifuga from Myanmar. J Nat Prod. 
2009;72(9):1631-1636.
 41. Youn UJ, Lee YS, Jeong H, et al. Identification 
of antiadipogenic constituents of the rhizomes 
of Anemarrhena asphodeloides. J Nat Prod. 
2009;72(10):1895-1898.
 42. Li M-C, Yao Z, Takaishi Y, Tang S-A, Duan H-Q. Isolation 
of novel phenolic compounds with multidrug resistance 
(MDR) reversal properties from Onychium japonicum. Chem 
Biodivers. 2011;8(6):1112-1120.
 43. Zhao H, Wang X, Li W, Koike K, Bai H. A new minor 
homoisoflavonoid from Caesalpinia sappan. Nat Prod Res. 
2014;28(2):102-105.
 44. LC F, Huang X, Lai ZY, YJ H, Liu HJ, Cai XL. A new 
3-benzylchroman derivative from sappan Lignum 
(Caesalpinia sappan). Molecules. 2008;13(8):1923-1930.
 45. Jeong HJ, Kim YM, Kim JH, et al. Homoisoflavonoids 
from Caesalpinia sappan displaying viral neuraminidases 
inhibition. Biol Pharm Bull. 2012;35(5):786-790.
 46. Dai Y, Harinantenaina L, Brodie PJ, et al. Antiproliferative 
homoisoflavonoids and bufatrienolides from Urginea 
depressa. J Nat Prod. 2013;76(5):865-872.
 47. Chen H, Li Y-J, Li X-F, et al. Homoisoflavanones with 
estrogenic activity from the rhizomes of Polygonatum 
sibiricum. J Asian Nat Prod Res. 2018;20(1):92-100.
 48. Yan J, Sun L-R, Zhou Z-Y, et al. Homoisoflavonoids from 
the medicinal plant Portulaca oleracea. Phytochemistry. 
2012;80:37-41.
 49. Tsai Y-C, Chiang S-Y, El-Shazly M, et al. The oestrogenic 
and anti-platelet activities of dihydrobenzofuroisocoumarins 
and homoisoflavonoids from Liriope platyphylla roots. Food 
Chem. 2013;140(1-2):305-314.
 50. Zhou X, Yuping Z, Zhao H, Liang J, Zhang Y, Shi S. 
Antioxidant homoisoflavonoids from Polygonatum 
odoratum. Food Chem. 2015;186:63-68.
 51. Tchegnitegni BT, Teponno RB, Tanaka C, Gabriel 
AF, Tapondjou LA, Miyamoto T. Sappanin-type 
homoisoflavonoids from Sansevieria trifasciata Prain. 
Phytochem Lett. 2015;12:262-266.
 52. Ata A, Gale EM, Samarasekera R. Bioactive chemical 
constituents of Caesalpinia bonduc (Fabaceae). Phytochem 
Lett. 2009;2(3):106-109.
 53. Schwikkard SL, Whitmore H, Corson TW, et al. 
Antiangiogenic activity and cytotoxicity of triterpenoids and 
homoisoflavonoids from Massonia pustulata and Massonia 
bifolia. Planta Med. 2018;84(9-10):638-644.
 54. El-Elimat T, Rivera-Chávez J, Burdette JE, et al. Cytotoxic 
homoisoflavonoids from the bulbs of Bellevalia flexuosa. 
Fitoterapia. 2018;127:201-206.
 55. Schwikkard S, Alqahtani A, Knirsch W, et al. Phytochemical 
investigations of three Rhodocodon (Hyacinthaceae Sensu 
APG II) species. J Nat Prod. 2017;80(1):30-37.
 56. Bezabih M, Famuyiwa SO, Abegaz BM. HPLC analysis and 
NMR identification of homoisoflavonoids and stilbenoids 
from the inter-bulb surfaces of Scilla nervosa. Nat Prod 
Commun. 2009;4(10):1367-1370.
 57. Matsuo Y, Kurihara R, Akagi N, Mimaki Y. Two new 
homoisoflavonoids from the bulbs of Bessera elegans. Nat 
Prod Commun. 2014;9(12):1725-1727.
Natural Product Communications18
 58. Li L-M, Yuan Q-P, Chen G. Four homoisoflavonoids isolated 
from traditional Chinese medicine: "gan luo xin". J Asian 
Nat Prod Res. 2014;16(8):813-818.
 59. Gan L-S, Chen J-J, Shi M-F, Zhou C-X. A new 
homoisoflavanone from the rhizomes of Polygonatum 
cyrtonema. Nat Prod Commun. 2013;8(5):597-598.
 60. Zhang H, Yang F, Qi J, et al. Homoisoflavonoids from the 
fibrous roots of Polygonatum odoratum with glucose uptake-
stimulatory activity in 3T3-L1 adipocytes. J Nat Prod. 
2010;73(4):548-552.
 61. Wang W, Dabu X, He J, et al. Polygonatone H, a new 
homoisoflavanone with cytotoxicity from Polygonatum 
Cyrtonema Hua. Nat Prod Res. 2018;46:1-7.
 62. Nishida Y, Eto M, Miyashita H, et al. A new homostilbene 
and two new homoisoflavones from the bulbs of Scilla 
scilloides. Chem Pharm Bull. 2008;56(7):1022-1025.
 63. Alali F, El-Elimat T, Albataineh H, et al. Cytotoxic 
homoisoflavones from the bulbs of Bellevalia eigii. J Nat 
Prod. 2015;78(7):1708-1715.
 64. Hafez Ghoran S, Saeidnia S, Babaei E, et al. Biochemical 
and biophysical properties of a novel homoisoflavonoid 
extracted from Scilla persica HAUSSKN. Bioorg Chem. 
2014;57:51-56.
 65. Wang D, Li D, Zhu W, Peng P. A new C-methylated 
homoisoflavanone and triterpenoid from the rhizomes of 
Polygonatum odoratum. Nat Prod Res. 2009;23(6):580-589.
 66. Cuong TD, Hung TM, Kim JC, et al. Phenolic compounds 
from Caesalpinia sappan heartwood and their anti-
inflammatory activity. J Nat Prod. 2012;75(12):2069-2075.
 67. Liu J, Mei W-L, Wu J, Zhao Y-X, Peng M, Dai H-F. A new 
cytotoxic homoisoflavonoid from Dracaena cambodiana. J 
Asian Nat Prod Res. 2009;11(2):192-195.
 68. Xu S, Shang M-Y, Liu G-X, et al. Chemical constituents 
from the rhizomes of Smilax glabra and their antimicrobial 
activity. Molecules. 2013;18(5):5265-5287.
 69. Koorbanally C, Sewjee S, Mulholland DA, Crouch NR, Dold 
A. Homoisoflavanones from Pseudoprospero firmifolium 
of the monotypic tribe Pseudoprospereae (Hyacinthaceae: 
Hyacinthoideae). Phytochemistry. 2007;68(22-
24):2753-2756.
 70. Tantray MA, Shawl AS, Khuroo MA, Ali N. 
Homoisoflavanones from Lespedeza juncea. Chem Nat 
Compd. 2008;44(4):424-426.
 71. Roy SK, Agrahari UC, Gautam R, Srivastava A, Jachak 
SM, Isointricatinol JSM. Isointricatinol, a new antioxidant 
homoisoflavonoid from the roots of Caesalpinia digyna 
Rottler. Nat Prod Res. 2012;26(8):690-695.
 72. Chen P, Yang J-S. Flavonol galactoside caffeiate ester and 
homoisoflavones from Caesalpinia millettii HOOK. et ARN. 
Chem Pharm Bull. 2007;55(4):655-657.
 73. Maheswara M, Siddaiah V, Venkata Rao C, Rao C. Two new 
homoisoflavonoids from Caesalpinia pulcherrima. Chem 
Pharm Bull. 2006;54(8):1193-1195.
 74. Das B, Thirupathi P, Ravikanth B, Aravind Kumar R, Sarma 
AVS, Basha SJ. Isolation, synthesis, and bioactivity of 
homoisoflavonoids from Caesalpinia pulcherrima. Chem 
Pharm Bull. 2009;57(10):1139-1141.
 75. Waller CP, Thumser AE, Langat MK, Crouch NR, 
Mulholland DA. COX-2 inhibitory activity of 
homoisoflavanones and xanthones from the bulbs of the 
southern African Ledebouria socialis and Ledebouria 
ovatifolia (Hyacinthaceae: Hyacinthoideae). Phytochemistry. 
2013;95:284-290.
 76. Che Y-Y, Qian Y, Wu Y, Wei-Qu , Liang J-Y. Two new 
Homoisoflavanones from the rhizome of Polygonatum 
odoratum. Chem Nat Compd. 2015;51(1):54-56.
 77. Koorbanally C, Crouch NR, Langlois A, Du Toit K, 
Mulholland DA, Drewes SE. Homoisoflavanones and 
spirocyclic nortriterpenoids from three Eucomis species: E. 
comosa, E. schijffii and E. pallidiflora subsp. pole-evansii 
(Hyacinthaceae). South Afr J Bot. 2006;72(3):428-433.
 78. Hafez Ghoran S, Saeidnia S, Babaei E, Kiuchi F, Hussain 
H. Scillapersicene: a new homoisoflavonoid with cytotoxic 
activity from the bulbs of Scilla persica HAUSSKN. Nat 
Prod Res. 2016;30(11):1309-1314.
 79. Ngamga D, Bipa J, Lebatha P, et al. Isoquinoline alkaloids 
and homoisoflavonoids from Drimiopsis barteri Bak and D. 
burkei Bak. Nat Prod Commun. 2008;3(5):769-777.
 80. Xu H-X, Lee SF. The antibacterial principle of Caesalpina 
sappan. Phytother Res. 2004;18(8):647-651.
 81. Lee EB, Xing MM, Kim DK. Lifespan-extending and 
stress resistance properties of Brazilin from Caesalpinia 
sappan in Caenorhabditis elegans. Arch Pharm Res. 
2017;40(7):825-835.
 82. Batubara I, Mitsunaga T, Ohashi H. Brazilin from 
Caesalpinia sappan wood as an antiacne agent. J Wood Sci. 
2010;56(1):77-81.
 83. Lee S, Choi S-Y, Choo Y-Y, et al. Sappanone A exhibits anti-
inflammatory effects via modulation of Nrf2 and NF-κB. Int 
Immunopharmacol. 2015;28(1):328-336.
 84. Rivero-Cruz JF. Antimicrobial compounds isolated 
from Haematoxylon brasiletto. J Ethnopharmacol. 
2008;119(1):99-103.
 85. Wang H, Fowler MI, Messenger DJ, et al. 
Homoisoflavonoids are potent glucose transporter 2 
(GLUT2) inhibitors: a potential mechanism for the glucose-
lowering properties of Polygonatum odoratum. J Agric Food 
Chem. 2018;66(12):3137-3145.
 86. Guo H, Zhao H, Kanno Y, et al. A dihydrochalcone 
and several homoisoflavonoids from Polygonatum 
odoratum are activators of adenosine monophosphate-
activated protein kinase. Bioorg Med Chem Lett. 
2013;23(11):3137-3139.
 87. Lin H-R. Two homoisoflavonoids act as peroxisome 
proliferator-activated receptor agonists. Med Chem Res. 
2015;24(7):2898-2905.
 88. Uesawa Y, Sakagami H, Kagaya H, Yamashita M, 
Takao K, Sugita Y. Quantitative structure-cytotoxicity 
relationship of 3-benzylidenechromanones. Anticancer Res. 
2016;36(11):5803-5812.
Abegaz and Kinfe 19
 89. Singh VK, Arora D, Satija NK, Khare P, Roy SK, Sharma 
PK. Intricatinol synergistically enhances the anticancerous 
activity of cisplatin in human A549 cells via p38 MAPK/p53 
signalling. Apoptosis. 2017;22(10):1273-1286.
 90. Lin L-G, Xie H, Li H-L, et al. Naturally occurring 
homoisoflavonoids function as potent protein tyrosine kinase 
inhibitors by c-Src-based high-throughput screening. J Med 
Chem. 2008;51(15):4419-4429.
 91. Lin L-G, Xie H, Wang Y-T, Ding J, Ye Y. Chemical 
constituents from the heartwood of Haematoxylon 
campechianum as protein tyrosine kinase inhibitors. Chem 
Biodivers. 2014;11(5):776-783.
 92. Liang C-H, Chan L-P, Chou T-H, et al. Brazilein from 
Caesalpinia sappan L. Antioxidant inhibits adipocyte 
differentiation and induces apoptosis through caspase-3 
activity and anthelmintic activities against Hymenolepis 
nana and Anisakis simplex. Evid Based Complement Alternat 
Med. 2013;2013(6):864892
 93. Yang X, Ren L, Zhang S, Zhao L, Wang J. Antitumor effects 
of purified protosappanin B extracted from Lignum Sappan. 
Integr Cancer Ther. 2016;15(1):87-95.
 94. Shim JS, Kim JH, Lee J, Kim SN, Kwon HJ. Anti-
angiogenic activity of a homoisoflavanone from Cremastra 
appendiculata. Planta Med. 2004;70(2):171-173.
 95. Amin SA, Adhikari N, Gayen S, Jha T. 
Homoisoflavonoids as potential antiangiogenic agents 
for retinal neovascularization. Biomed Pharmacother. 
2017;95:818-827.
 96. Basavarajappa HD, Lee B, Lee H, et al. Synthesis and 
biological evaluation of novel homoisoflavonoids for retinal 
neovascularization. J Med Chem. 2015;58(12):5015-5027.
 97. Lin M, Sun W, Gong W, Zhou Z, Ding Y, Hou Q. 
Methylophiopogonanone A protects against cerebral 
ischemia/reperfusion injury and attenuates blood−brain 
barrier disruption in vitro. PLoS One. 2015;10(4):1-14.
 98. Lin Y-F, Fong C, Peng W-L, Tang K-C, Liang Y-E, Li 
W-T. Synthesis of 3-(2-olefinbenzyl)-4H-chromen-4-
one through cyclobenzylation and catalytic C-H bond 
functionalization using palladium (II). J Org Chem. 
2017;82(20):10855-10865.
 99. Raja GCE, Ryu JY, Lee J, Lee S. Ruthenium-catalyzed 
C-H activation of salicylaldehyde and decarboxylative 
coupling of alkynoic acids for the selective synthesis 
of homoisoflavonoids and flavones. Org Lett. 
2017;19(24):6606-6609.
 100. Devarajan K, Devaraj S, Balasubramanian KK, Bhagavathy 
S. An unexpected thermal [1,3]-[1,3]- para rearrangement 
of chromone-3-ylmethyl aryl ethers: mechanism and 
application of the intercepted [1,3]-rearranged intermediates 
to the synthesis of cis-homopterocarpans. Chem Lett. 
2015;44(4):551-553.
 101. Tinto WF, Simmons-Boyce JL, McLean S, Reynolds WF. 
Constituents of Agave americana and Agave barbadensis. 
Fitoterapia. 2005;76(6):594-597.
 102. Y-C Y, Zhu S, X-W L, Wu Y, Liu B. Enantioselective 
synthesis of four natural homoisoflavonoids. Eur J Organ 
Chem. 2015;2015(22):4964-4972.
 103. Camarda L. Merlini l, Nasini G. Dragon’s blood from 
Dracaena draco, Structure of novel homoisoflavonoids. 
Heterocycles. 1983;20(1):39-43.
 104. Singh DK, Jung Y, Kim I. Total syntheses of urgineanins A, 
B, D, and their analogues. Synthesis. 2017;49(7):1531-1537.
 105. Boehler P, Tamm C. The homo-isoflavones, a new class 
of natural product. Isolation and structure of eucomin and 
eucomol. Tetrahedron Lett. 1967;8(36):3479-3483.
 106. Krawczyk E, Koprowski M, Mielniczak G, Owsianik 
K. Symmetric synthesis of 5,7-O-dimethyleucomols via 
enantioselective oxidation of enol phosphates. Tetrahedron 
Asymmetry. 2015;26(15-16):876-883.
 107. Takikawa H, Suzuki K. Modified chiral triazolium salts 
for enantioselective benzoin cyclization of enolizable 
keto-aldehydes: Synthesis of (+)-sappanone B. Organ Lett. 
2007;9(14):2713-2716.
 108. Yen CT, Nakagawa-Goto K, Hwang TL, et al. Antitumor 
agents. 271: total synthesis and evaluation of brazilein and 
analogs as anti-inflammatory and cytotoxic agents. Bioorg 
Med Chem Lett. 2010;20(3):1037-1039.
 109. Yadav JS, Mishra AK, Das S. Formal synthesis of 
(±)-brazilin and total synthesis of (±)-brazilane. Tetrahedron. 
2014;70(41):7560-7566.
 110. Wang X, Zhang H, Yang X, Zhao J, Pan C. Enantioselective 
total synthesis of (+)-brazilin, (−)-brazilein and (+)-brazilide 
A. Chem Commun. 2013;49(47):5405-5407.
 111. Devarajan K, Devaraj S, Balasubramanian KK, Bhagavathy 
S. An unexpected thermal [1,3]-[1,3]- para rearrangement 
of chromone-3-ylmethyl aryl ethers: mechanism and 
application of the intercepted [1,3]-rearranged intermediates 
to the synthesis of cis -homopterocarpans. Chem Lett. 
2015;44(4):551-553.
